相关实验视频

Updated: May 5, 2026

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

在非小细胞肺癌中透瘤的B细胞:当前的见解和未来的方向

Shuyue Jiang¹, Daxing Zhu², Ye Wang³

¹Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.

Cancer cell international

|February 26, 2025

概括

在非小细胞肺癌 (NSCLC) 中,瘤透B细胞 (TIL-Bs) 的研究越来越多. 本综述详细介绍了它们在NSCLC中的作用,亚型和治疗潜力.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
细胞生物学细胞生物学

背景情况:

透瘤的免疫细胞显著影响瘤的进展.
瘤微环境中的B淋巴细胞正在成为研究重点.
在非小细胞肺癌 (NSCLC) 中,B细胞的特定功能尚不清楚.

研究的目的:

审查目前对NSCLC中B淋巴细胞的理解.
描述NSCLC中B细胞的分布,表型和异质性.
讨论涉及瘤透B细胞 (TIL-Bs) 的预后价值和治疗策略.

主要方法:

关于NSCLC中B细胞的最近研究的文献综述.
对B细胞分布,表型和异质性的分析.
评估B细胞功能和预后意义.

主要成果:

在NSCLC微环境中,B细胞表现出多样化的分布和表型.
特定的B细胞亚型可能在瘤促进或抑制中发挥不同的作用.
在TIL-Bs.中识别潜在的治疗点.

结论:

B细胞是NSCLC瘤微环境的复杂组成部分.
了解B细胞异质性对于预测预后和开发疗法至关重要.
需要进一步的研究,以充分阐明TIL-Bs在NSCLC中的精确功能.

关键词:

幽默性免疫力幽默性免疫力非小细胞肺癌的非小细胞肺癌.瘤微环境是一个微环境.透瘤的B型淋巴细胞

更多相关视频

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.